Clinical trial for the control of osteonecrosis of the femoral head secondary to the initial corticosteroid treatment in patients with systemic lupus erythematosus - Control of steroid-induced osteonecrosis of the femoral head in SLE patients

Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University0 个研究点目标入组 150 人开始时间: 2012年6月22日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•A. Objectives have never had corticosteroid treatment before the entry to the trial. B. Objectives have never been affected with osteonecrosis of the femoral head. C. Patients with any active bleeding lesion. D. Patients with any active infection. E. Patients have any contraindication to candidate drugs for the prevention. F. Patients have any past histories of anaphylaxis to candidate drugs for the prevention. G. Female in pregnancy, lactation period, having a possibility of pregnancy. H. Patients taking below contraindicative drugs. 1. antiplatelet drugs expect clopidogrel 2. anticoagulant 3. cyclosporine 4. fibrates I. Patients that have contraindication for MRI. J. Patients that are considered unsuitable for the entry to the trial.

发起方

Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University